U S Physical Therapy Inc (USPH) stock
USPHNYSEServices-Health ServicesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 9/3022% above fair value
$98.60−1.50 (-1.50%)
Close on Nov 12, 2026Market cap $1.47BP/E –Yield 1.83%
U S Physical Therapy EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
U S Physical Therapy's EPS for the twelve months ending Sep 30, 2025 was $2.47. For fiscal 2025 it was $1.42, down 22.8% from the year before. Over ten years it grew -1.5% a year on average. The highest annual figure on record is $2.48 in fiscal 2020.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.42 | -22.8% |
| FY2024 | Dec 31, 2024 | $1.84 | +43.8% |
| FY2023 | Dec 31, 2023 | $1.28 | -43.1% |
| FY2022 | Dec 31, 2022 | $2.25 | -6.6% |
| FY2021 | Dec 31, 2021 | $2.41 | -2.8% |
| FY2020 | Dec 31, 2020 | $2.48 | +1.2% |
| FY2019 | Dec 31, 2019 | $2.45 | +87.0% |
| FY2018 | Dec 31, 2018 | $1.31 | -25.6% |
| FY2017 | Dec 31, 2017 | $1.76 | +7.3% |
| FY2016 | Dec 31, 2016 | $1.64 | -1.2% |
| FY2015 | Dec 31, 2015 | $1.66 | +5.7% |
| FY2014 | Dec 31, 2014 | $1.57 | +49.5% |
| FY2013 | Dec 31, 2013 | $1.05 | -30.5% |
| FY2012 | Dec 31, 2012 | $1.51 | -13.7% |
| FY2011 | Dec 31, 2011 | $1.75 | +32.6% |
| FY2010 | Dec 31, 2010 | $1.32 | +32.0% |
| FY2009 | Dec 31, 2009 | $1.00 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$1.04 | -279.3% |
| Q2 FY2026 | Jun 30, 2026 | $0.25 | -68.8% |
| Q1 FY2026 | Mar 31, 2026 | -$0.12 | -119.7% |
| Q3 FY2025 | Sep 30, 2025 | $0.48 | +23.1% |
| Q2 FY2025 | Jun 30, 2025 | $0.58 | +23.4% |
| Q1 FY2025 | Mar 31, 2025 | $0.80 | +73.9% |
| Q4 FY2024 | Dec 31, 2024 | $0.61 | +19.6% |
| Q3 FY2024 | Sep 30, 2024 | $0.39 | -39.1% |
| Q2 FY2024 | Jun 30, 2024 | $0.47 | -19.0% |
| Q1 FY2024 | Mar 31, 2024 | $0.46 | +130.0% |
| Q3 FY2023 | Sep 30, 2023 | $0.51 | -29.2% |
| Q2 FY2023 | Jun 30, 2023 | $0.64 | -26.4% |
| Q1 FY2023 | Mar 31, 2023 | $0.58 | -13.4% |
| Q4 FY2022 | Dec 31, 2022 | $0.20 | -74.7% |
| Q3 FY2022 | Sep 30, 2022 | $0.72 | +9.1% |
| Q2 FY2022 | Jun 30, 2022 | $0.87 | +6.1% |
| Q1 FY2022 | Mar 31, 2022 | $0.67 | +219.0% |
| Q4 FY2021 | Dec 31, 2021 | $0.79 | -21.8% |
| Q3 FY2021 | Sep 30, 2021 | $0.66 | +8.2% |
| Q2 FY2021 | Jun 30, 2021 | $0.82 | -17.2% |
| Q1 FY2021 | Mar 31, 2021 | $0.21 | +5.0% |
| Q4 FY2020 | Dec 31, 2020 | $1.01 | +83.6% |
| Q3 FY2020 | Sep 30, 2020 | $0.61 | -7.6% |
| Q2 FY2020 | Jun 30, 2020 | $0.99 | +16.5% |
| Q1 FY2020 | Mar 31, 2020 | $0.20 | -48.7% |
| Q4 FY2019 | Dec 31, 2019 | $0.55 | +27.9% |
| Q3 FY2019 | Sep 30, 2019 | $0.66 | +407.7% |
| Q2 FY2019 | Jun 30, 2019 | $0.85 | +77.1% |
| Q1 FY2019 | Mar 31, 2019 | $0.39 | +44.4% |
| Q4 FY2018 | Dec 31, 2018 | $0.43 | -24.6% |
| Q3 FY2018 | Sep 30, 2018 | $0.13 | -68.3% |
| Q2 FY2018 | Jun 30, 2018 | $0.48 | +23.1% |
| Q1 FY2018 | Mar 31, 2018 | $0.27 | -28.9% |
| Q4 FY2017 | Dec 31, 2017 | $0.57 | +35.7% |
| Q3 FY2017 | Sep 30, 2017 | $0.41 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.39 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.38 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.42 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?